已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Characteristics and Trend of Drug-Resistant Tuberculosis at a Major Specialized Hospital in Chongqing, China: 2016 Versus 2019

医学 肺结核 广泛耐药结核 抗药性 内科学 药品 耐药结核 耐多药结核病 结核分枝杆菌 药理学 病理 生物 微生物学
作者
Huizheng Zhang,Ke Zhang,Xin Yang,Ming Luo,Chunhua Li,Xiaoying Wang,Kui Hu
出处
期刊:Disaster Medicine and Public Health Preparedness [Cambridge University Press]
卷期号:17
标识
DOI:10.1017/dmp.2022.88
摘要

Abstract Objective: The epidemic of drug-resistant tuberculosis (DR-TB) has become a major concern in global TB control. This study aimed to investigate the patterns and trend of DR-TB epidemic between different time periods in Chongqing. Methods: A total of 985 and 835 culture positive TB patients with drug susceptibility testing (DST) results admitted to the hospital in 2016 and 2019, respectively, were included. Chi-square testing was used to compare the prevalence and trends of DR-TB in 2016 and 2019. Results: The proportion of previously treated TB cases with culture positivity was 45.7% in 2019, significantly higher than that in 2016 (39.1%, P = 0.004). The overall rate of drug resistance in 2019 was 43.1%, higher than that in 2016 (40.2%). The rates of multi-drug resistant TB (MDR-TB) and pre-extensively drug resistant TB (pre-XDR-TB) increased significantly from 2016 to 2019 among all TB cases (MDR: 25% vs 33.4%, P < 0.001 and pre-XDR: 7.1% vs 12.8%, P < 0.001, respectively) and previously treated TB cases (MDR: 46.5% vs 56%, P = 0.008 and pre-XDR: 13.2% vs 21.5%, P = 0.003, respectively). Conclusions: Our findings indicated that the prevalence of DR-TB remains high in Chongqing. The trend of resistance to anti-TB drugs beccame worse between 2016 and 2019. Moreover, acquired MDR may play a major role in MDR-TB epidemic in Chongqing. Therefore, rapid diagnosis and effective treatment of TB patients will be important to reduce the burden of DR-TB in Chongqing.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
建议保存本图,每天支付宝扫一扫(相册选取)领红包
实时播报
激动的鹰完成签到,获得积分10
1秒前
Sailzyf完成签到,获得积分10
2秒前
万能图书馆应助化雪彼岸采纳,获得10
3秒前
伍声痕完成签到,获得积分10
3秒前
sdadadas发布了新的文献求助10
4秒前
4秒前
纪红琴发布了新的文献求助10
6秒前
6秒前
6秒前
夏小胖完成签到,获得积分10
7秒前
8秒前
Lucas应助未来采纳,获得10
8秒前
超级小飞侠完成签到,获得积分10
9秒前
kai chen完成签到 ,获得积分0
11秒前
uikymh完成签到 ,获得积分0
13秒前
故人无碑关注了科研通微信公众号
13秒前
Wff发布了新的文献求助10
13秒前
14秒前
汉堡包应助小王采纳,获得10
16秒前
张泽林完成签到 ,获得积分10
17秒前
jieni发布了新的文献求助10
19秒前
123完成签到,获得积分10
19秒前
李健完成签到 ,获得积分10
22秒前
浮游应助科研通管家采纳,获得10
24秒前
科研通AI2S应助科研通管家采纳,获得10
24秒前
Momomo应助科研通管家采纳,获得10
24秒前
浮游应助科研通管家采纳,获得10
24秒前
浮游应助科研通管家采纳,获得10
24秒前
CodeCraft应助科研通管家采纳,获得10
24秒前
科研通AI2S应助科研通管家采纳,获得10
24秒前
浮游应助科研通管家采纳,获得10
24秒前
浮游应助科研通管家采纳,获得10
24秒前
25秒前
25秒前
25秒前
25秒前
为医消得人憔悴完成签到,获得积分10
26秒前
充电宝应助希拉里罗德姆采纳,获得30
26秒前
月落无痕2025完成签到,获得积分10
28秒前
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1041
Mentoring for Wellbeing in Schools 1000
Binary Alloy Phase Diagrams, 2nd Edition 600
Atlas of Liver Pathology: A Pattern-Based Approach 500
A Technologist’s Guide to Performing Sleep Studies 500
EEG in Childhood Epilepsy: Initial Presentation & Long-Term Follow-Up 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5493520
求助须知:如何正确求助?哪些是违规求助? 4591654
关于积分的说明 14434304
捐赠科研通 4524048
什么是DOI,文献DOI怎么找? 2478552
邀请新用户注册赠送积分活动 1463558
关于科研通互助平台的介绍 1436393